The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
基本信息
- 批准号:7259418
- 负责人:
- 金额:$ 12.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdenosineAdenosine A2A ReceptorAdenosine A3 ReceptorAgonistAmericanAngiotensinsApoptosisApplications GrantsBlood flowCanis familiarisCardiacCardiologyCardiomyopathiesCardiovascular PhysiologyCardiovascular systemChronicClinicalCollectionCommitCongestive Heart FailureContrast echocardiography procedureCoronaryCoronary ArteriosclerosisDataDeveloped CountriesDevelopmentEchocardiographyEnhancersEnvironmentEnzyme-Linked Immunosorbent AssayEquipmentEvaluationFacultyFellowshipFunctional disorderGoalsGrantHealthHistologicHistopathologyImageImmunohistochemistryInflammationInflammatoryInjection of therapeutic agentInstitutionIntercellular FluidInternal MedicineInternationalInvasiveIschemiaLaboratoriesLearningLeft Ventricular DysfunctionLeft Ventricular FunctionLeft Ventricular MassLeukocytesMagnetic Resonance ImagingMedicalMedicineMentorsMicrobubblesMicrospheresModelingMorbidity - disease rateMyocardialMyocardial perfusionMyocardiumPathogenesisPathway interactionsPerfusionPharmacologyPhysiologyPrevalenceProtocols documentationPublicationsRadioimmunoassayReceptor ActivationReninResearchResearch PersonnelResearch ProposalsResidenciesRoleSumTechniquesTherapeuticTiliaTimeTrainingTranslational ResearchUltrasonographyUniversitiesVasodilationVirginiaWorkameroidangiogenesisauthoritycareercollegecytokinemortalitytool
项目摘要
DESCRIPTION (provided by applicant):
The candidate received superb training in myocardial contrast echocardiography (MCE) and coronary physiology research in Dr. Sanjiv Kaul's experimental laboratory and is committed to the development of an academic career in cardiovascular medicine. The K08 grant would allow her to achieve her immediate career goals, which are to continue to develop expertise in the field of MCE as new ultrasound equipment and microbubbles are developed, to gain an understanding of the pathogenesis of chronic ischemic cardiomyopathy, to learn histopathologic, immunohistochemical, ELISA, EIA, RIA, and SPA techniques, and to become familiar with cardiac MRI as a research tool. Her long-term career goals include development into an independent investigator in the experimental laboratory in the subject of chronic LV dysfunction and MCE, participation in translational research protocols with a focus on chronic ischemia and therapeutics for ischemic congestive heart failure (CHF), and practicing clinical cardiology with an emphasis on coronary artery disease and echocardiography. In sum, she is committed to developing a successful academic career in cardiovascular medicine. CHF is a major health problem in industrialized countries and its prevalence, morbidity, and mortality are rapidly rising. The pathophysiology of ischemic CHF is not well understood. The overall aim of this research proposal is to investigate the role of adenosine in chronic ischemic cardiomyopathy in a canine model of ameroid-induced left ventricular (LV) dysfunction. An A1 allosteric enhancer, a selective A2A agonist and antagonist, and a selective A3 agonist will be given to study their effects on angiogenesis, apoptosis, inflammation, vasodilation, and cardioprotection. At baseline, maximal LV dysfunction, and 1 month, 3 months, and 6 months after administration of the adenosine agonist or antagonist, we will perform MCE to examine myocardial perfusion and angiogenesis, contrast echo imaging of inflammation, MRI to examine myocardial mass, LV volume, and regional and global LV function, microspheres injection to assess myocardial blood flow, and interstitial fluid collection from the myocardium to examine the presence of cytokines and white blood cells. After the 6-month evaluation, histopathology and immunohistochemistry will be performed to correlate functional changes with histologic evidence of inflammatory changes, apoptosis, and angiogenesis. The research environment involves close mentoring by Drs. Kaul and Siragy, use of their lab space, and enthusiastic support from the division chief and consultants, including Dr. Joel Linden who is an authority on the role of adenosine in cardiovascular physiology and pharmacology.
描述(由申请人提供):
这位候选人在Sanjiv Kaul博士的实验实验室接受了心肌声学造影(MCE)和冠状动脉生理学研究方面的精湛培训,并致力于心血管医学学术生涯的发展。K08的资助将使她能够实现她当前的职业目标,即随着新的超声设备和微泡的开发,继续发展MCE领域的专业知识,了解慢性缺血性心肌病的发病机制,学习组织病理学、免疫组织化学、ELISA、EIA、RIA和SPA技术,并熟悉作为研究工具的心脏MRI。她的长期职业目标包括在实验实验室发展成为慢性左心功能不全和慢性心肌梗死的独立研究员,参与专注于慢性缺血和缺血性充血性心力衰竭(CHF)治疗的转化性研究方案,以及从事临床心脏病学,重点是冠状动脉疾病和超声心动图。总而言之,她致力于在心血管医学领域发展成功的学术生涯。充血性心力衰竭是工业化国家的一个主要健康问题,其患病率、发病率和死亡率正在迅速上升。缺血性充血性心力衰竭的病理生理学机制尚不清楚。这项研究的总体目标是在无水乙醇诱导的左心功能不全的犬模型中,研究腺苷在慢性缺血性心肌病中的作用。A1变构增强剂、选择性A2A激动剂和拮抗剂以及选择性A3激动剂将用于研究它们在血管生成、细胞凋亡、炎症、血管扩张和心脏保护方面的作用。在基线、最大左心功能不全时,以及应用腺苷激动剂或拮抗剂后1个月、3个月和6个月,我们将进行MCE检查以检查心肌灌注和血管生成,炎症的对比回声成像,MRI检查心肌质量、左室容量、局部和整体左心功能,注射微球以评估心肌血流,并收集心肌间质液体以检查细胞因子和白细胞的存在。在6个月的评估后,将进行组织病理学和免疫组织化学检查,以将功能变化与炎性变化、细胞凋亡和血管生成的组织学证据相关联。研究环境包括Kaul博士和Siragy博士的密切指导,他们实验室空间的使用,以及部门负责人和顾问的热情支持,包括乔尔·林登博士,他是腺苷在心血管生理学和药理学中的作用方面的权威。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dai-Trang Elizabeth Le其他文献
RANOLAZINE EXHIBITS ANTI-ISCHEMIC PROPERTIES BY INCREASING CARDIAC ENDOTHELIAL CELL ADENOSINE LEVELS
- DOI:
10.1016/s0735-1097(19)30657-6 - 发表时间:
2019-03-12 - 期刊:
- 影响因子:
- 作者:
Dai-Trang Elizabeth Le;Catherine Davis;Shanthi Nagarajan;Kristin L. Lyon Scott;Zhiping Cao;Helen Liu;Alkayed Nabil;Sanjiv Kaul - 通讯作者:
Sanjiv Kaul
INTRAVENOUS RANOLAZINE RELIEVES ISCHEMIA BY INCREASING MYOCARDIAL ADENOSINE LEVELS
- DOI:
10.1016/s0735-1097(15)61571-6 - 发表时间:
2015-03-17 - 期刊:
- 影响因子:
- 作者:
Dai-Trang Elizabeth Le;Kevin Wei;Yan Zhao;Matthew Nugent;Luiz Belardinelli;Sanjiv Kaul - 通讯作者:
Sanjiv Kaul
RANOLAZINE RELIEVES ISCHEMIA BY DECREASING MYOCARDIAL WORK WITHOUT ALTERING MYOCARDIAL BLOOD FLOW: INSIGHTS FROM AN EXPERIMENTAL MODEL
- DOI:
10.1016/s0735-1097(14)61522-9 - 发表时间:
2014-04-01 - 期刊:
- 影响因子:
- 作者:
Dai-Trang Elizabeth Le;Kevin Wei;Yan Zhao;Matthew Nugent;Sanjiv Kaul - 通讯作者:
Sanjiv Kaul
Dai-Trang Elizabeth Le的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dai-Trang Elizabeth Le', 18)}}的其他基金
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
- 批准号:
7225364 - 财政年份:2003
- 资助金额:
$ 12.78万 - 项目类别:
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
- 批准号:
6677645 - 财政年份:2003
- 资助金额:
$ 12.78万 - 项目类别:
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
- 批准号:
7110909 - 财政年份:2003
- 资助金额:
$ 12.78万 - 项目类别:
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
- 批准号:
6802263 - 财政年份:2003
- 资助金额:
$ 12.78万 - 项目类别:
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
腺苷在慢性缺血性心肌病中的作用
- 批准号:
6946495 - 财政年份:2003
- 资助金额:
$ 12.78万 - 项目类别:
相似海外基金
Mechanism of allosteric action of extracellular ATP at the adenosine A2a receptor
细胞外 ATP 对腺苷 A2a 受体的变构作用机制
- 批准号:
570072-2022 - 财政年份:2022
- 资助金额:
$ 12.78万 - 项目类别:
Postgraduate Scholarships - Doctoral
Targeting the Host Adenosine A2A Receptor to Protect Against Fatal Rickettsiosis Using an Approved Parkinson's Disease Drug
使用经批准的帕金森病药物靶向宿主腺苷 A2A 受体来预防致命的立克次体病
- 批准号:
9510124 - 财政年份:2018
- 资助金额:
$ 12.78万 - 项目类别:
Structure and Dynamics of Adenosine A2A receptor - Gs Complexes
腺苷 A2A 受体 - Gs 复合物的结构和动力学
- 批准号:
382662 - 财政年份:2018
- 资助金额:
$ 12.78万 - 项目类别:
Operating Grants
Understanding the Allosteric Regulation of Adenosine A2A Receptor by Metal Cations
了解金属阳离子对腺苷 A2A 受体的变构调节
- 批准号:
515106-2017 - 财政年份:2017
- 资助金额:
$ 12.78万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
靶向肺癌患者的腺苷 A2A 受体免疫检查点
- 批准号:
9175600 - 财政年份:2016
- 资助金额:
$ 12.78万 - 项目类别:
Molecular imaging of adenosine A2A receptor: a first-in-human study
腺苷 A2A 受体的分子成像:首次人体研究
- 批准号:
16H05396 - 财政年份:2016
- 资助金额:
$ 12.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Anti-inflammatory activities of the adenosine A2A receptor in human neutrophils: delineation of resolution and anti-ageing pathways
人中性粒细胞中腺苷 A2A 受体的抗炎活性:解析和抗衰老途径的描述
- 批准号:
351807 - 财政年份:2016
- 资助金额:
$ 12.78万 - 项目类别:
Operating Grants
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
靶向肺癌患者的腺苷 A2A 受体免疫检查点
- 批准号:
9462266 - 财政年份:2016
- 资助金额:
$ 12.78万 - 项目类别:
Effects of Adenosine A2a receptor deficiency on a-synuclein-induced neurotoxicity
腺苷 A2a 受体缺陷对 a-突触核蛋白诱导的神经毒性的影响
- 批准号:
15K09308 - 财政年份:2015
- 资助金额:
$ 12.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Adenosine A2A receptor cross-activation of TrkB in Huntington's disease
亨廷顿病中 TrkB 的腺苷 A2A 受体交叉激活
- 批准号:
8104912 - 财政年份:2011
- 资助金额:
$ 12.78万 - 项目类别:














{{item.name}}会员




